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Abstract 
Introduction: Recreational drug-related 
hospital admissions, excluding alcohol, 
appeared to be relatively constant in Mater 
Dei Hospital (MDH), Malta’s sole public, 
acute general hospital. While ‘classical’ 
recreational drugs such as cocaine, heroin 
and Methylenedioxymethamphetamine 
(MDMA) were always seen as the main 
culprits, intoxications secondary to novel 
psychoactive substances (NPS) have 
recently emerged in MDH. The aim of this 
study was to determine the challenges of 
acute recreational drug intoxication, 
including NPS, in MDH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methods: All MDH admissions 
secondary to acute recreational drug 
intoxication between 2010 and 2015 were 
investigated. MDH clinical performance unit 
(CPU), hospital data files, hospital discharge 
letters and the hospital database software 
system were utilised for data collection. 
Intoxications associated with deliberate self-
harm, mechanical injury and lone alcohol 
ingestions were excluded. 
Results: 286 patients were admitted to 
MDH with recreational drug intoxication 
between 2010-2015, with a peak of 71 
patients in 2015.  78.3% were males and the 
median age was 26 years.  While 79% of the 
admissions were Maltese nationals, there 
was a surge in foreigner admissions, from 
11.8% between 2010-2012 to 28.3% 
between 2013-2015 (p<0.001). Admissions 
occurred mostly in spring and summer, on 
Saturday or Sunday, and at night. 52.4% of 
admissions were acutely confused. Ethanol 
co-ingestion (40.9%) and polydrug use 
(39.9%) were common in these admissions.  
16% needed admission to critical care. 
91.3% admissions were secondary to 
‘Classical’ recreational drugs, mostly heroin 
and cocaine. In 2015, 36.6% of admissions 
were secondary to NPS, mostly synthetic 
cannabinoids (SCRA). SCRA admissions 
were associated with severe 
sympathomimetic and neuropsychiatric 
features.  An SCRA toxidrome mnemonic 
(MEET_SCRA) is proposed from the most 
common features of lone intoxications. 
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Conclusion: Recreational drugs were 
associated with significant hospital burden, 
with NPS representing a new threat to MDH 
and Maltese public health.  The toxidrome 
mnemonic MEET_SCRA could potentially 
aid in the identification of SCRA 
intoxications. 
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Introduction  
Recreational drug intoxications, 
excluding alcohol, presenting to the 
Emergency department (ED) in Europe is a 
common problem resulting in between 0.3% 
to 0.45% of their ED attendances in studies 
by Dines et al.1 and Liakoni et al.2 
Similar ED data from the Unites States 
(US) shows a worse picture, with about 2.5 
million patients or 2% of the total ED visits 
resulting from drug abuse or misuse in 2011, 
of which 51% were attributable to illicit 
drug use.3 Apart from the classical 
psychoactive substances, NPS, often known 
as ‘Legal Highs’, started to appear 
worldwide in the mid-2000s, specifically 
designed to evade drug laws with the 
potential of causing grave threats to public 
safety.4   Recent studies from European and 
US ED’s showed an increase in reported 
NPS intoxications, with resulting increased 
challenges for these already strained 
departments.1,3,5 
Malta is the smallest country member 
of the European Union, with a population of 
around 425,000 in 20136 and is a major 
tourist destination with around 1.6 million 
tourists every year, including many young 
adults.7 
MDH has an inpatient bed capacity of 
949 beds, including 20 intensive care beds, 
with the ED seeing an average of 110,000 
patients per year.8 A total of 27,158 patients 
were admitted through the ED in 2012.9 
Throughout the years, recreational drug-
related admissions to MDH appeared to be 
relatively constant with cocaine, heroin and 
MDMA being the main culprits, especially 
in the summer period.  This correlates well 
with studies showing increased prevalence 
of recreational drug use in places of 
recreation.10-11 
The aim was to describe the trends and 
impact of recreational drugs between 2010 
and 2015 on MDH, and the impact of novel 
psychoactive substances in the local scene. 
Finally, this audit will attempt to describe 
the toxidrome for SCRA toxicity that will 
hopefully aid future professionals dealing 
with such NPS poisonings. 
 
Method 
All the patients admitted to MDH with 
acute recreational drug intoxication in the 6-
year period (1st January 2010 to the 31st 
December 2015) were included in this 
retrospective study. 
For the aims of this study, only patients 
admitted to hospital secondary to acute 
intoxication from a drug taken for 
recreational purposes ‘to get a high’ were 
included.  Thus, patients with deliberate 
self-harm or when it was not clear whether 
the admissions were directly related to drug 
intoxication (e.g. mechanical injury or 
withdrawal), were excluded.   
Patients admitted to hospital with lone 
alcohol intoxication were excluded.  Patients 
admitted to hospital following misuse of 
pharmaceuticals were included only if it was 
deemed that these drugs were used for 
recreational purposes.  Recreational drugs 
were deemed to have been involved if the 
patient self-reported their use, or if these 
were later found in drug toxicology tests, one 
not excluding the other. In cases where 
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patients abused of a recreational drug while 
on a prescribed medication/s, the prescribed 
medication/s were added to the study only if 
the patient self-reported its use as a 
recreational drug, or if drug toxicology tests 
tested positive for a psychotropic drug that 
was not their routine medication on 
admission.  The patients admitted after 
intoxication from a self-reported use of a 
lone SCRA, were further investigated by 
gathering data on their baseline parameters 
and clinical features in an attempt to describe 
a SCRA toxidrome. Information was 
gathered through the hospital CPU data, 
using a clinical coding system based on 
discharge letters.  Data was also gathered 
through the patient discharge notes (through 
an electronic case summary software 
database), through patient medical records, 
and through the use of a hospital database 
software system (I-Soft Clinical Manager®). 
 
Statistical Analysis 
Continuous variables were presented as 
mean (standard deviation) and median 
(interquartile range) for non-Gaussian 
variables and were compared by the Mann-
Whitney U test.  Pearson’s chi-square test or 
Fisher’s exact test (where appropriate) were 
performed to compare multiple categorical 
variables, presented as number (percentage) 
for the time period 2010 to 2015. Since the 
overall numbers were small, these were also 
grouped in two time periods (2010-2012 and 
2013-2015) so as to increase statistical 
significance. Data analyses was carried out 
via Excel® 2011 and SPSS-software, version 
19.0. Armonk, NY: IBM Corp. A p-value 
<0.05 was considered statistically 
significant. 
 
Results 
Admissions to MDH (2010-2015) 
In total, 286 patients were admitted to 
MDH with acute recreational drug 
intoxication in the 6-year period between 1st 
January 2010 and 31st December 2015.  The 
average number of admissions in this period 
was 47.7, with a peak of 71 admissions in 
2015. 
 
Patient Demographics 
Male patients constituted 224 (78.3%) 
of the admissions between 2010 and 2015. 
There was no statistically significant 
difference across the genders during the 6-
year period (Table 1).  The mean (SD) age 
between 2010 and 2015 was 28.3 (9.68) 
years, while the median age (IQR, range) 
was 26 (20-34, 13-60) years.  The median 
(IQR, range) age for males was 27.5 (22-35, 
14-60) years while that for females was 22 
(18.3-31.8, 13-50) years (p=0.002).  226 
(79%) of all admissions to MDH between 
2010 and 2015 were Maltese nationals. 
Foreigner admissions increased from 11.8% 
between 2010-2012 to 28.3% between 2013-
2015 (p<0.001) (Table 1). 
Spring and summer (Table 1) were the 
most common seasons for admissions, while 
the fewest presentations occurred in 
February (Fig.1). 
Saturday (50, 17.5%) and Sunday (61, 
21.3%) were the most common days of 
presentation, with Tuesday being the least 
common date of admission (30, 10.5%) (Fig. 
2). 
136 or 47.6% of presentations occurred 
during the weekend (Friday 17:00hrs-
Monday 07.59hrs).  There was no 
statistically significant difference in this 
trend between 2010-2015 (Table 1). 145 or 
50.7% were night presentations (20:00hrs-
07.59hrs).  There was a statistically 
significant increase in night presentations in 
the latter years (2013-2015) as compared to 
the earlier years (2010-2012) (p=0.017) 
(Table 1). 
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Table 2: The number of admissions secondary to the most common recreational drugs 
compared across the earlier (2010-2012) and latter (2013-2015) years. 
 
 
The most common 
recreational drugs 
Number of admissions involving 
recreational drug N, percentage of 
admissions 2010-2015 (%) 
 
 
2010-2012 
 
 
2013-2015 
 
 
P-value 
 N (%) N (%) N (%)  
Heroin 126  (44.1) 62 (48.8) 64 (40.3) 0.147# 
Cocaine 119 (41.6) 48 (37.8) 71 (44.7) 0.242# 
MDMA/ 
methamphetamine 
/amphetamine 
 
 
63 (22) 
 
 
38 (29.9) 
 
 
25 (15.7) 
 
 
0.004# 
Cannabis 54 (18.5) 24 (18.9) 29 (18.2) 0.887# 
SCRA 26 (9.1) 0 (0) 26 (16.4) <0.0001* 
Benzodiazepines 25 (8.7) 11 (8.7) 14 (8.8) 0.966# 
Synthetic 
Cathinones 
11 (3.8) 9 (7.1) 2 (1.3) 0.013* 
       Statistical tests used - #: Pearson’s chi square test, *: Fisher’s exact test used 
 
Figure 1:  Percentage admission per month (2010-2015) 
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Table 1: Multiple categorical variables with their respective p-value between 2010-2015 
and for the grouped years 2010-2012 and 2013-2015. 
  
  2010 2011 2012 2013 2014 2015 P-value 2010-2012 2013-2015 P-value 
  N (%) N (%) N (%) N (%) N (%) N (%)  N (%) N (%)  
Gender Male 
31 
(79.5) 
44  
(88) 
30 
(78.9) 
32 
(84.2) 
39 
(78) 48 (67.6) 0.136$ 105 (82.7) 
119  
(74.8) 0.11$ 
 Female 
8 
(20.5) 6 (12) 
8 
(21.1) 
6 
(15.8) 
11 
(22) 23 (32.4)  22 (17.3) 
40   
(25.2)  
            
Nationality Maltese 
37 
(94.9) 
46 
(92) 
29 
(76.3) 
31 
(81.6) 
36 
(72) 47 (66.2) 0.001* 112  (88.2) 
114  
(71.7) 0.001$ 
 Foreign 2 (5.1) 4 (8) 
9 
(23.7) 
7 
(18.4) 
14 
(28) 24 (33.8)  15   (11.8) 
45   
(28.3)  
            
Ward Normal 
35 
(89.7) 
40 
(80) 
35 
(92.1) 
25 
(65.8) 
45 
(90) 59 (83.1) 0.028* 110  (86.6) 
129  
(81.1) 0.261$ 
 Critical care 
4 
(10.3) 
10 
(20) 3 (7.9) 
13 
(34.2) 5 (10) 12 (16.9)  17   (13.4) 
30   
(18.9)  
            
Weekend No 
24 
(61.5) 
27 
(54) 
23 
(60.5) 
15 
(39.5) 
21 
(42) 39 (54.9) 0.205$ 74   (58.3) 
75   
(47.2) 0.074$ 
 Yes 
15 
(38.5) 
23 
(46) 
15 
(39.5) 
23 
(60.5) 
29 
(58) 32 (45.1)  53   (41.7) 
84   
(52.8)  
            
Night No 23 (59) 
32 
(64) 
18 
(47.4) 
17 
(44.7) 
20 
(40) 31 (43.7) 0.118$ 73   (57.5) 
68   
(42.8) 0.017$ 
 Yes 16 (41) 
18 
(36) 
20 
(52.6) 
21 
(55.3) 
30 
(60) 40 (56.3)  54   (42.5) 
91   
(57.2)  
            
Season 
Winter 
(December-
February) 
8 
(20.5) 
14 
(28) 
7 
(18.4) 
4 
(10.5) 8 (16) 7 (9.9) 0.004* 29  (22.8) 
19  
(11.9) 0.006$ 
 
Spring (March-
May) 
7 
(17.9) 
10 
(20) 3 (7.9) 
11 
(28.9) 7 (14) 29 (40.8)  20  (15.7) 
47  
(29.6)  
 
Summer (June-
August) 
14 
(35.9) 
13 
(26) 
19 
(50) 
9 
(23.7) 
16 
(32) 21 (29.6)  46  (36.2) 
46  
(28.9)  
 
Autumn 
(September-
November) 
10 
(25.6) 
13 
(26) 
9 
(23.7) 
14 
(36.8) 
19 
(38) 14 (19.7)  32  (25.2) 
47  
(29.6)  
            
Day of the 
Week Monday 
7 
(17.9) 6 (12) 
8 
(21.1) 3 (7.9) 6 (12) 10 (14.1) <0.0001* 21   (16.5) 
19   
(11.9) 0.53$ 
 Tuesday 
5 
(12.8) 2 (4) 
9 
(23.7) 
4 
(10.5) 4 (8) 6 (8.5)  16   (12.6) 
14   
(8.8)  
 Wednesday 
7 
(17.9) 6 (12) 2 (5.3) 1 (2.6) 3 (6) 12 (16.9)  15   (11.8) 
16   
(10.1)  
 Thursday 
6 
(15.4) 
10 
(20) 3 (7.9) 
4 
(10.5) 7 (14) 12 (16.9)  19   (15) 
23   
(14.5)  
 Friday 2 (5.1) 6 (12) 
7 
(18.4) 
7 
(18.4) 4 (8) 6 (8.5)  15   (11.8) 
17   
(10.7)  
 Saturday 3 (7.7) 
11 
(22) 3 (7.9) 
10 
(26.3) 
10 
(20) 13 (18.3)  17   (13.4) 
33   
(20.8)  
 Sunday 
9 
(23.1) 9 (18) 
6 
(15.8) 
9 
(23.7) 
16 
(32) 12 (16.9)  24   (18.9) 
37   
(23.3)  
            
Ethanol No 
22 
(56.4) 
35 
(70) 
18 
(47.4) 
20 
(52.6) 
26 
(52) 48 (67.6) 0.128$ 75   (59.1) 
94   
(59.1) 1$ 
 Yes 
17 
(43.6) 
15 
(30) 
20 
(52.6) 
18 
(47.4) 
24 
(48) 23 (32.4)  52   (40.9) 
65   
(40.9)  
            
Number of 
agents taken 
 
Single 
23 (59) 28 
(56) 
21 
(55.3) 
22 
(57.4) 
36 
(72) 
44 (62) 0.574$ 72 (56.7) 102 
(64.2) 
0.199$ 
 Multiple 16 (41) 22 
(44) 
17 
(44.7) 
16 
(42.1) 
14 
(28) 
27 (38)  55 (43.3) 57 
(35.8) 
 
N: number; Statistical tests used - $: Pearson chi-square test; *: Fisher’s exact test 
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Figure 2: Percentage of admissions per day of the week (2010-2015). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:  Percentage of admissions per number of recreational drugs taken between 2010 
and 2015 
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Figure 4: All the recreational drugs taken (including NPS in black), between 2010-2015. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recreational drugs taken 
There were 456 reported recreational 
drugs out of a total of 284 admissions. 
Ethanol was co-ingested in 40.9% of all 
admissions, with no significant difference 
across the years (Table 1).   As shown in 
Fig. 3, a single agent was involved in most 
admissions (172, 60.1%), with no 
statistically significant change in the number 
of drugs taken (single or multiple) across the 
6-year period (Table 1). 
Of the total number of drugs taken 
(456), ‘classical’ recreational drugs were the 
most commonly involved with 362 (79.4%) 
of the total recreational drugs taken, while 
there were 42 (9.2%) reported NPS (SCRA, 
synthetic cathinones and phenylpiperazine) 
(Fig. 4). 
‘Classical’ recreational drugs such as 
heroin, and cocaine were involved in 261 
(91.3%) of the total admissions, while NPS 
were present in 37 (12.9%) of the 
admissions between 2010 and 2015. 15 of 
these 37 NPS admissions involved both 
‘Classical’ recreational drugs and NPS.  Of 
these NPS, SCRA were first reported in an 
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MDH admission in 2015, and resulted in 
36.6% of all recreational drug admissions in 
that year. 
43 (9.4%) pharmaceutical medications 
were taken in 34 admissions (11.9%) for 
recreational purposes. Of these 
benzodiazepines were the most common 
(26, 60.5%), with diazepam (16, 37.2%), 
being the commonest pharmaceutical drug. 
 
Severity of the admissions 
The average length of stay (LOS) 
between 2010 and 2015 was 47.2hours, 
while the median (IQR) LOS was 38 (23-
50.9) hours.  The median (IQR, range) GCS 
at admission to ED between 2010 and 2015 
was 14 (13-15, 3-15), while the average 
GCS at ED was 13.2. There was no 
statistically significant difference in GCS 
between genders (p=0.239).  27 (9.44%) 
patients had a GCS of less than or equal to 8 
on admission (comatose), while 123 (43%) 
had a GCS of between 9 and 14.  47 patients 
(16.4%) required admission to either cardiac 
critical care unit (CCCU) or intensive care 
unit (ITU). 
 
Novel psychoactive substances 
NPS were present in 37 (12.9%) 
admissions between 2010-2015, involving 
42 (9.2%) reported NPS.  26 SCRA, 15 
synthetic cathinones (MDPV, 
dimethcathinone, mephedrone, pentedrone, 
PVP and pyrovalerone) and 1 piperazine 
(mCPP) were involved.  When NPS 
admissions were compared with Non-NPS 
admissions there was no statistical 
difference in terms of median GCS 
(p=0.297), critical bed usage (p=0.213) or 
median LOS (p=0.977).  
 
Synthetic cannabinoid receptor agonists 
(SCRA) 
Admissions secondary to self-reported 
SCRA intoxication were analysed in order 
to attempt to identify a toxidrome. In total, 
18 cases were included out of a total of 26 
cases of self-reported SCRA use.  One 
medical file could not be retrieved and 6 
other cases had either consumed alcohol or 
other drugs together with SCRA. 13 (72.2%) 
were males and 11 (61.1%) were foreign 
nationals. 
 
MEET_SCRA 
The most common features were 
mydriasis (66.7%), emesis (50%), euphoria 
(38.9%), tachycardia (77.8%), sweating 
(38.9%) and seizures (22.2%), confusion 
[GCS<15] (77.8%), respiratory depression 
(44.4%), respiratory acidosis (33.3%), 
anxiety (61.1%)/ agitation (79.9%). From 
these features a mnemonic for the toxidrome 
of SCRA intoxication is proposed 
(MEET_SCRA). 
 
Discussion 
Admissions with recreational drug 
intoxication 
286 patients were admitted for 
recreational drug intoxication between the 
1st of January 2010 and the 31st of December 
2015.  This represents 0.18% of the total ED 
admissions per year in MDH.6 There was 
however a significant increase in the number 
of admissions in 2015 (0.26%), which 
would approach European figures [1, 2]. 
 
Demographics 
The patients’ age and gender ratios 
compared well with other European studies 
(median age of 26 years) with males 
amounting for more than three quarters of 
the MDH admissions. 1,12 79% of the MDH 
recreational drug admissions were Maltese, 
however over the latter years there was a 
statistically significant increase in the 
number of foreigners. This was likely due to 
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the recent increase in immigration, with 
Malta recording amongst the highest 
population growth rates in 2013.13 
Most of these admissions attended 
during the night and in the summer period, 
while Saturday and Sunday were the most 
common days of admission (Table 1 and 
Fig. 2). This correlates well with a study by 
Dines et al.1 and with the fact that some 
social settings like clubbing, increase the 
risk of recreational drug consumption.14 
 
Severity of the admissions 
The average LOS during this 6-year 
period was 47.2 hours, with a median of 38 
hours.  Comparison with the European study 
by Dines et al.8 with a LOS of 4.6 hours 
(IQR 2.5-9.9 hours) was not possible, since 
this study included discharges from the ED. 
The median GCS upon admission to the 
ED was 14 while the average GCS was 13.2.  
The fact that 27 (9.44%) patients were 
comatose and that 123 (43%) had a GCS of 
between 9 and 14 on admission, indicates 
the severity of such intoxications and 
compares well with other studies.1-2 47 
patients (16.4%) were admitted to critical 
care.  When comparing NPS admissions to 
non-NPS admissions, there was no-
statistical change in terms of severity (LOS, 
median GCS and critical bed usage).  
However, note is made of the small numbers 
of the sample which might have affected the 
statistical outcome. 
 
Recreational drugs taken 
The high rate of ethanol co-ingestion 
(40.9%) and poly-drug use (39.9%) in these 
admissions relates well with other European 
studies.1-2 
‘Classical’ recreational drugs, 
especially heroin and cocaine were the most 
common recreational drugs over the 6-year 
period (379, 83.1%).  Pharmaceutical drugs 
were taken for recreational purposes in 
11.9% of these admissions.  In the MDH 
study, only 3 patients took them as a lone 
drug (excluding alcohol).  Thus, the lone 
intake of a pharmaceutical drug to ‘get a 
high’ remains a very rare occurrence in 
MDH admissions. 
 
Novel psychoactive substances (NPS) 
NPS were present in 37 (12.9%) of all 
admissions and included 42 (9.2%) reported 
NPS.  This percentage of reported NPS was 
twice as common in Malta than in the 
European study by Dines et al.1 In 2015, 27 
(24.3%) NPS were reported in 26 (36.6%) 
admissions, hence being significantly more 
than the latter study.  Synthetic cathinones 
“bath salts” were more common in the 
earlier years (2010-2012), and have 
decreased over the latter years (2013-2015) 
(p=0.013) (Table 2). 
The only piperazine reported, meta-
Chlorophenylpiperazine (mCPP) was 
detected by GC/MS in 2010 and was found 
in a polydrug admission (together with 
MDMA and cocaine).  The reasons for such 
decrease in reported synthetic cathinones 
and piperazines could be a change in trend 
use, decreased availability, or possibly the 
scheduling of such drugs.  Mephedrone 
became scheduled by legal notice in Malta 
in 2010.15 Also, the mass spectrometer of 
the GC-MS available at the MDH laboratory 
had not been functional for the last 6 months 
of 2015. 
The fact that some users might be 
acquiring different contents, or actually 
different recreational drugs, to what they paid 
for, has also been mentioned in the literature.16-
17 This might be the reason why some patients 
had not self-reported the use of synthetic 
cathinones, even when these drugs were still 
not scheduled in Malta.  MDPV for instance, 
only became scheduled in Malta in 2016.18 
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Table 3: Clinically reported features of SCRA intoxications 
 Total Number (N) = 18 (%) 
Cardiovascular   
Tachycardia (>100bpm) 14 77.8 
Bradycardia (<60bpm) 0 0 
Hypotension (Systolic blood pressure<90) 1 5.6 
Arrhythmias 0 0 
Palpitations 2 11.1 
Chest pain 1 5.6 
Arrhythmias (apart from sinus tachycardia) 0 0 
   
Respiratory   
Hyperventilation 4 22.2 
Respiratory depression: pCO2 (> 45mmHg) 8 44.4 
   
Neurological/Psychiatric   
Anxiety 11 61.1 
Euphoria 7 38.9 
Headache 1 5.6 
Agitation/Aggressiveness 13 72.2 
Psychosis 2 11.1 
Hallucinations 3 16.7 
Amnesia 4 22.2 
Seizures 3 16.7 
Twitching of muscles (myoclonus) 2 11.1 
Cerebellar features 3 16.7 
Pupils – Mydriasis 12 66.7 
Pupils – Miosis 0 0 
Pre-hospital 'Alert' on AVPU scale 7 38.9 
Pre-hospital 'Not Alert’ on AVPU scale i.e. V, P or U /low GCS 11 61.1 
GCS on arrival to ED = 15 4 22.2 
GCS on arrival to ED 9-14 13 72.2 
GCS on arrival to ED < or = 8 1 5.6 
   
Others   
Lactate >=2.0 7 38.9 
Acidosis (pH <7.35) 6 33.3 
Alkalosis (pH >7.45) 1 5.6 
Nausea or vomiting 9 50 
Respiratory acidosis only (pH <7.45, pCO2 >45mmHg, Bicarbonate 
> 21) 6 33.3 
Metabolic acidosis only (pH <7.45, pC02 <=45mmHg, HCO3 <21) 0 0 
Mixed metabolic and respiratory acidosis 2 11.1 
Glucose level >9 <11.1 5 27.8 
Glucose level >=11.1 2 11.1 
Hyperthermia (>39degrees Celsius) 0 0 
Hypothermia (<35 degrees Celsius) 3 16.7 
Sweating 7 38.9 
Acute kidney injury 6 33.3 
Hypokalaemia (K+ < 3.5) 5 27.8 
 
CasOrgOdRe 
 
 
 
Original Article 
 
   Malta Medical School Gazette     Volume 01 Issue 04 2017                                                                                                                              
                                               
 
 
Synthetic cannabinoid receptor agonists 
(SCRA) 
SCRA were first reported in MDH 
admissions in the beginning of April 2015.  
From then onwards, 26 (36.6%) admissions 
in 2015 were from SCRA.  This represented 
only the self-reported intoxications since 
there is no liquid chromatography-tandem 
Mass Spectroscopy (LC-MS/MS) or other 
analytical screen able to detect SCRA at 
present in Malta, and no samples were sent 
for testing abroad.   
Sympathomimetic toxicity, respiratory 
complications and neuropsychiatric 
symptoms, were the most common reported 
features of lone SCRA intoxications (Table 
3). This collated well with a study by 
Hermanns-Clausen et al.19 involving a small 
sample of patients with confirmed SCRA 
intoxication. 
Fourteen (77.8%) patients in the MDH 
study had documented tachycardia (range 
102-145bpm).  All of these patients were 
treated symptomatically for the tachycardia, 
and all had normalization of their heart rate 
within a few hours. 
A significant number of patients had 
respiratory depression in this study, and this 
is supported by an early study on SCRA 
effects on animals.20 While the study by 
Hermanns-Clausen et al.19 does not mention 
respiratory depression or acidosis, it does 
emphasise the fact that a third of the patients 
displayed somnolence for several hours, 
“but still had sufficient respiration”.  It is 
reasonable to assume that respiratory 
depression might have been present at some 
point during this period of decreased 
consciousness.  2 case reports documenting 
SCRA-associated respiratory depression in 
two young males, both of whom required 
intubation, were described by Jinwala and 
Gupta.21 
In the study by Hermanns-Clausen et 
al.19 no patients had acute kidney injury 
(AKI), as defined by KDIGO22 while this 
was present in 6 lone SCRA intoxications 
admitted to MDH. All of these admissions 
involved young males (16 to 36 years). Four 
of these 6 AKI’s were hypotensive, or had 
documented fluid loss, such as sweating, 
vomiting or excessive physical activity.  
However, in 2 of these 6 cases neither 
rhabdomyolysis nor a pre-renal injury 
appear to fully explain the AKI, suggesting 
a SCRA-associated intrinsic AKI.  AKI has 
been associated with SCRA in 16 US 
patients, with 6 out of 8 of such patients 
who had a renal biopsy, showing acute 
tubular injury, while 3 out of these patients 
showing features of acute interstitial 
nephritis.23 Of these 16 patients, five 
required haemodialysis, most recovering 
within 3 days of the creatinine peak, with no 
reported deaths.23 While MDH cases had 
normalisation of their levels within a 
maximum of 10 days, with none needing 
dialysis, two patients were discharged home 
before documented normalisation of their 
renal function. 
Three patients (16.7%) in this study had 
generalised seizures, all of which were 
treated conservatively and none had status 
epilepticus. SCRA have been associated 
with seizure activity.24 
A toxidrome mnemonic “MEET_SCRA” is 
proposed from the results of this study, as an 
aid in diagnosing patients intoxicated with 
SCRA.  
 
Conclusion 
Recreational drug use is a significant 
healthcare burden in MDH.  Although the 
number of admissions is relatively small, 
these appear to be on the increase, with a 
substantial increase in 2015.  More than half 
of such patients were confused (GCS<15), 
and 16.4% needed critical care. 
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‘Classical’ recreational drugs are the 
most common recreational drugs associated 
with admissions. NPS however have 
become an important threat from a public 
health perspective.  More than a third of all 
admissions in 2015 involved a NPS (SCRA 
or synthetic cathinones).  A large proportion 
of the SCRA-associated admissions were 
severe, with respiratory depression, acidosis 
and low GCS.  Although SCRA symptoms 
appeared to improve relatively quickly, a 
third of patients with lone SCRA 
intoxication had AKI, 16.7% had seizures, 
and more than a quarter of such admissions 
needed critical care. 
The use of the toxidrome mnemonic 
‘MEET_SCRA’ is proposed in order to 
facilitate patient diagnosis in cases of SCRA 
intoxication. 
 
Limitations 
Since admission records was obtained 
from a clinical coding system based on 
discharge letters, admissions that had no 
discharge letter done were not included.  
Such might have occurred if the patient self-
discharged or died during that admission. 
This study only included patients admitted 
to MDH.  While the admissions likely 
reflected those patients that had the more 
severe symptoms, it also excludes a large 
cohort of patients that were discharged from 
the ED. 
This study was based substantially on 
the self-reporting of recreational drugs 
taken, and this also depends on the patient’s 
attitude towards possible legal 
repercussions. 
There is currently no available LC-
MS/MS in Malta, thus, SCRA and some 
other NPS could not be detected. 
The mass spectrometer of the GC-MS in the 
MDH laboratory was not operational from 
mid-2015 onwards, due to a malfunction.  
This might have resulted in less reported 
NPS in the latter half of 2015. 
 
Recommendations 
Further research on the pharmacology 
and toxicology of recreational drugs 
including NPS, and their impact on hospitals 
locally and internationally is recommended. 
The use of the toxidrome mnemonic 
‘MEET_SCRA’ is proposed in order to 
facilitate patient diagnosis in cases of SCRA 
intoxication. 
A LC-MS/MS and a better-equipped 
hospital laboratory would be a valuable 
asset in early identification of recreational 
drug outbreaks, such as with SCRA in 2015. 
In 2016, Malta joined the Euro-DEN 
project25 which aims to identify recreational 
drug use presenting to European ED’s. Such 
data can be of help to local and EU policy 
makers, when deciding on future healthcare 
implementations on this subject. 
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